Thermo Fisher Scientific Inc Stock News

CVS should benefit from rising demand for health insurance and medications. Thermo Fisher Scientific is a key provider of medical supplies to the drug industry.

While the smaller-capitalization trades tend to attract the most speculative attention, for reliable upside prospects, investors may want to consider blue-chip stocks to buy. To better understand the

Investors continue to be optimistic about Thermo Fisher's (TMO) continued strength across its end markets and the the execution of the growth strategy.

Thermo Fisher's (TMO) OrbitrapTM AstralTM mass spectrometer enables accurate and exact quantification in proteomics laboratories.

Thermo Fisher Scientific has experienced significant growth over the past 20 years, with a 14% CAGR in revenue and a 17% CAGR in adjusted EPS. Despite headwinds from the COVID-19 pandemic and inflatio

Thermo Fisher Scientific Inc. (NYSE:TMO ) Bernstein 39th Annual Strategic Decisions Conference Call May 31, 2023 11:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive

The "Halftime Report" traders give their top picks to watch for the second half.

Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.

Thermo Fisher (TMO) announces the FDA clearance of its blood-based biomarkers used in the determination of risk assessment and clinical management of preeclampsia with severe features.

Thermo Fisher Scientific (NYSE:TMO) announced that the U.S. Food and Drug Administration (FDA) has cleared its Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR

The U.S. Food and Drug Administration (FDA) has cleared the first test to detect women with risk of severe preeclampsia, a leading cause of pregnancy-related illness and death in the United States, Th

Thermo Fisher Scientific Inc.

Nanotechnology refers to technologies based on materials between 1 and 100 nanometers in size, which is the microscopic level. Accordingly, the production of such materials from nanotechnology stocks

Daniel Morris, manager of top mutual fund Manor Growth Fund (MNRGX), admits he has a conservative streak. The post This Top Fund Manager Buys Growth Stocks Without Paying Too Much appeared first on In

Stalwarts are companies that have stood the test of time without trouble. Thermo Fisher's recent headwinds should have little impact on its long-term outlook.